C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 311/09 (2006.01) A61P 27/02 (2006.01)
Patent
CA 2361906
Improved water-soluble drugs which can inhibit carbonic anhydrase isozymes inside mammalian eyes are disclosed, for use in eyedrops by patients suffering from glaucoma or ocular hypertension. These compounds have a fluorinated (preferably perfluorinated) alkyl, aryl, or cycloalkyl group, coupled to an aromatic or heterocyclic ring with a pendant sulfonamide group. These new fluoro-sulfonamide compounds have several advantages over previously known CAI's used in eyedrops, such as dorzolamide and brinzolamide. These advantages include: (1) higher solubility in water, allowing fluoro-sulfonamides to be dissolved at desired concentrations in neutral aqueous solution without requiring potentially irritating acidifying or suspending agents; (2) ability to reduce intraocular pressure by more than twice as much as dorzolamide (e. g., 10.3 to 12.5 mm Hg in normal rabbits, compared to 4.1 for dorzolamide; 13.0 to 15.7 in glaucomatous rabbits, compared to 6.7 for dorzolamide); and, (3) substantially longer duration of action. Any of those results would be deemed important, in glaucoma treatments the fact that all three results were achieved simultaneously indicates that these new fluoro- sulfonamide drugs offer major improvements over the prior art.
Casini Angela
Menabuoni Luca
Mincione Francesco
Mincione Giovanna
Scozzafava Andrea
Casini Angela
Menabuoni Luca
Mincione Francesco
Mincione Giovanna
Scozzafava Andrea
LandOfFree
Water-soluble fluorinated sulfonamides as topical carbonic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Water-soluble fluorinated sulfonamides as topical carbonic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Water-soluble fluorinated sulfonamides as topical carbonic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1419351